Application Note

Resolving Bottlenecks of Recombinant Antibody Fragments

Source: GE Healthcare Life Sciences
Resolving Bottlenecks of Recombinant Antibody Fragments

Antibodies and their derivatives are increasingly important and essential tools for biological research. Techniques to screen and characterize large numbers of antibodies and provide confident selection of the best candidates for development are therefore essential. Details described in this method will provide rapid screening in combination with data-rich selection of fragments with high affinity and the desired kinetic behavior.